Royal Fund Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Royal Fund Management's MDT Position: Q3 2026 in Review
Royal Fund Management reduced its Medtronic (MDT) stake by 67% in Q3 2026, selling an estimated $1.78M and leaving 9,775 shares worth $843K. The position accounts for 0.07% of the portfolio, ranked #201.
Royal Fund Management first reported a position in MDT in Q2 2017 and has held it in 17 quarters since. The position peaked at $2.57M in Q3 2025. 2,200 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Royal Fund Management held 9,775 shares of Medtronic worth $843K as of Q3 2026.
- Royal Fund Management sold 20,152 Medtronic shares in Q3 2026, an estimated $1.78M.
- Medtronic made up 0.07% of Royal Fund Management's portfolio in Q3 2026, its #201 holding.
- Royal Fund Management first reported a position in Medtronic in Q2 2017 and has held it in 17 quarters since.
- Royal Fund Management's Medtronic position peaked at $2.57M in Q3 2025.
- 2,200 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Royal Fund Management's 13F filing for Q3 2026, filed 22 Oct 2026.